Literature DB >> 10885407

Silicone granuloma on the entry points of acupuncture, venepuncture and surgical needles.

M Yanagihara1, T Fujii, N Wakamatu, H Ishizaki, T Takehara, K Nawate.   

Abstract

We describe a case of epithelioid granuloma on the entry points of needles used for acupuncture, venepuncture and for taking skin biopsy. The acupuncture needles used at each session were silicone coated. Silicon was detected in the vacuoles of macrophages and multiple nucleated giant cells by X-ray microanalysis. To our knowledge, this is the first case of silicone granuloma arising on the entry points of acupuncture, venepuncture and surgical needles.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10885407     DOI: 10.1034/j.1600-0560.2000.027006301.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  5 in total

1.  Systemic sarcoidosis revealed by venepunctures: a very rare but rewarding cutaneous manifestation.

Authors:  Martin Killian; Cyril Habougit; Eric Monard; Baptiste Gramont
Journal:  BMJ Case Rep       Date:  2020-09-07

2.  Prevention of polydimethylsiloxane microsphere migration using a mussel-inspired polydopamine coating for potential application in injection therapy.

Authors:  Eun-Jae Chung; Dae-Ryong Jun; Dong-Wook Kim; Mi-Jung Han; Tack-Kyun Kwon; Sung-Wook Choi; Seong Keun Kwon
Journal:  PLoS One       Date:  2017-11-02       Impact factor: 3.240

Review 3.  Botulinum neurotoxin formulations: overcoming the confusion.

Authors:  Souphiyeh Samizadeh; Koenraad De Boulle
Journal:  Clin Cosmet Investig Dermatol       Date:  2018-05-30

4.  The Biological Safety of Stainless Steel Needles Used in Warm-needling.

Authors:  Sabina Lim; Seunghun Lee; Seung-Ho Yi; Yang-Sun Son; Sung-Min Choi; Young-Kon Kim
Journal:  Evid Based Complement Alternat Med       Date:  2008-12-20       Impact factor: 2.629

5.  Adverse events of acupuncture: a systematic review of case reports.

Authors:  Shifen Xu; Lizhen Wang; Emily Cooper; Ming Zhang; Eric Manheimer; Brian Berman; Xueyong Shen; Lixing Lao
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-20       Impact factor: 2.629

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.